Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

QUINAPRIL 5 MG TABLET

quinapril
$0.0753per EA

Strength

5 mg/1

Manufacturer

Solco Healthcare US LLC

NDC

43547041009

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

1/18/2023

Active Ingredients

QUINAPRIL HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA205823

On Market Since

11/10/2017

Pharmacological Classes

Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

-6.5%

All

-44.2%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

LISINOPRIL 2.5 MG TABLET
Generic
65862003701•Aurobindo Pharma Limited
$0.0143
per EA
LISINOPRIL 2.5 MG TABLET
Generic
65862003705•Aurobindo Pharma Limited
$0.0143
per EA
LISINOPRIL 2.5 MG TABLET
Generic
65862003799•Aurobindo Pharma Limited
$0.0143
per EA
LISINOPRIL 2.5 MG TABLET
Generic
00591040501•Actavis Pharma, Inc.
$0.0144
per EA
LISINOPRIL 2.5 MG TABLET
Generic
00591040505•Actavis Pharma, Inc.
$0.0144
per EA
LISINOPRIL 2.5 MG TABLET
Generic
23155087601•Heritage Pharmaceuticals Inc.
$0.0144
per EA
LISINOPRIL 2.5 MG TABLET
Generic
23155087605•Heritage Pharmaceuticals Inc.
$0.0144
per EA
LISINOPRIL 2.5 MG TABLET
Generic
31722017201•Camber Pharmaceuticals Inc.
$0.0144
per EA
LISINOPRIL 2.5 MG TABLET
Generic
31722017205•Camber Pharmaceuticals Inc.
$0.0144
per EA
LISINOPRIL 2.5 MG TABLET
Generic
43547035110•Solco Healthcare US LLC
$0.0144
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy